| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |